AbbVie Inc.

AbbVie Inc.

233.75
CHF
+64.75
(+38.31%)
2.88EPS
59.79P/E
304.76BMarket Cap
Oct 30Next Earn

Valuation

Price vs. fair value · multiples
Price & Valuation BandSIGNATURE
Price against a fair-value channel (EPS × 12 / 15 / 23×)
+14.7% CAGROvervalued +337%
PriceFair value

Growth

Revenue · EPS · free cash flow
Revenue
Top line with YoY growth
+10.3% CAGR
RevenueYoY growth
EPS (Diluted)
Per-share earnings · loss years read red
-2.7% CAGR
EPSYoY growth
Free Cash Flow
Operating CF − capex, with FCF margin
Operating CFCapexFree cash flowFCF margin

Profitability

Margins & returns on capital
Gross Profit & Margin
Bars with margin trend line
+8.9% CAGR
Gross profitGross margin
Operating Income & Margin
Bars with margin trend line
+10.3% CAGR
Operating incomeOperating margin
Net Income & Margin
Loss years read red
-1.9% CAGR
Net incomeNet margin
ROIC · ROE · ROA
Returns on capital · ROE on right axis
-4.3% CAGR
ROICROEROA

Balance Sheet Health

Liquidity · leverage · share count
Cash vs. Debt
Liquidity & leverage, net-debt line
Cash & investmentsTotal debtNet debt
Shares Outstanding
Diluted share count · buybacks vs. dilution
+0.8% CAGR
Dividends & Payout Ratio
Dividend per share with payout overlay
+12.4% CAGR
Dividend / sharePayout ratio
roic.ai · Fundamentals charts. Figures are not investment advice.